SEK 37.0
(-1.99%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -43.65 Million DKK | -33.65% |
2022 | -32.66 Million DKK | -12.44% |
2021 | -29.05 Million DKK | -31.26% |
2020 | -22.13 Million DKK | -106.08% |
2019 | -10.74 Million DKK | -18834.55% |
2018 | -56.72 Thousand DKK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -8.11 Million DKK | 4.27% |
2024 Q1 | -8.34 Million DKK | 34.14% |
2023 Q3 | -10.86 Million DKK | -25.5% |
2023 FY | -43.92 Million DKK | -34.46% |
2023 Q4 | -12.67 Million DKK | -16.64% |
2023 Q2 | -8.65 Million DKK | 25.67% |
2023 Q1 | -11.64 Million DKK | -2.97% |
2022 FY | -32.66 Million DKK | -12.44% |
2022 Q3 | -8.41 Million DKK | -12.0% |
2022 Q2 | -7.51 Million DKK | -38.4% |
2022 Q1 | -5.42 Million DKK | 45.08% |
2022 Q4 | -11.3 Million DKK | -34.38% |
2021 Q3 | -8.93 Million DKK | -48.13% |
2021 Q2 | -6.03 Million DKK | -43.63% |
2021 Q1 | -4.2 Million DKK | 50.76% |
2021 FY | -29.05 Million DKK | -31.26% |
2021 Q4 | -9.88 Million DKK | -10.6% |
2020 FY | -22.13 Million DKK | -106.08% |
2020 Q4 | -8.53 Million DKK | -173.2% |
2020 Q3 | -3.12 Million DKK | 52.56% |
2020 Q2 | -6.58 Million DKK | -67.81% |
2020 Q1 | -3.92 Million DKK | -3.18% |
2019 Q4 | -3.8 Million DKK | 24.82% |
2019 Q3 | -5.05 Million DKK | -276.55% |
2019 Q2 | -1.34 Million DKK | -203.85% |
2019 Q1 | -442 Thousand DKK | -750.0% |
2019 FY | -10.74 Million DKK | -18834.55% |
2018 Q4 | -52 Thousand DKK | 0.0% |
2018 Q3 | - DKK | 0.0% |
2018 FY | -56.72 Thousand DKK | 0.0% |
2018 Q2 | - DKK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
AddLife AB (publ) | 585 Million SEK | 107.463% |
Biotage AB (publ) | 376 Million SEK | 111.611% |
Bonesupport Holding AB (publ) | 13.93 Million SEK | 413.417% |
Doxa AB (publ) | 269.4 Million SEK | 116.206% |
Elekta AB (publ) | 2.03 Billion SEK | 102.141% |
iZafe Group AB (publ) | -35.63 Million SEK | -22.517% |
Ortivus AB (publ) | -17.61 Million SEK | -147.893% |
Ortivus AB (publ) | -17.61 Million SEK | -147.893% |
Q-linea AB (publ) | -230.58 Million SEK | 81.066% |
S2Medical AB (publ) | -15.26 Million SEK | -186.028% |
Synsam AB (publ) | 696 Million SEK | 106.273% |